ConductScience.org, home

Paper1985208

Induction of high-titer neutralizing antibodies, using hybrid human immunodeficiency virus V3-Ty viruslike particles in a clinically relevant adjuvant.

Griffiths JC and 8 others. J Virol, 1991. Cited by 53 papers, by iCite.

Cite this record

ConductScience Library. Induction of high-titer neutralizing antibodies, using hybrid human immunodeficiency virus V3-Ty viruslike particles in a clinically relevant adjuvant. Papers, record 1985208. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1985208

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Induction of high-titer neutralizing antibodies, using hybrid human immunodeficiency virus V3-Ty viruslike particles in a clinically relevant adjuvant.
PubMed
Journal
J Virol
PubMed
Year
1991
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
53
iCite
Relative citation ratio, by iCite
1.31
iCite
Revised in PubMed
2020-07-24
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Griffiths JCJ C
2Berrie ELE L
3Holdsworth LNL N
4Moore JPJ P
5Harris SJS J
6Senior JMJ M
7Kingsman SMS M
8Kingsman AJA J
9Adams SES E

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, MonoclonalMajor topic
HIVMajor topic
HIV AntibodiesMajor topic
HIV Envelope Protein gp120Major topic
Amino Acid Sequence
Animals
Antibody Formation
Base Sequence
Binding Sites, Antibody
Freund's Adjuvant
Genetic Vectors
Molecular Sequence Data
Neutralization Tests
Protein Conformation
Rabbits

Source PubMed

Download CSV of topics

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13369091Envelope sequences of two new United States HIV-1 isolates.Virology1988https://conductscience.org/library/papers/3369091PubMed
21689753HIV p24-specific helper T cell clones from immunized primates recognize highly conserved regions of HIV-1.J Immunol1990https://conductscience.org/library/papers/1689753PubMed
32455898Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/2455898PubMed
42457809Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans.Nature1988https://conductscience.org/library/papers/2457809PubMed
52458487Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1.J Virol1988https://conductscience.org/library/papers/2458487PubMed
62845130Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4.J Virol1988https://conductscience.org/library/papers/2845130PubMed
72846691Inhibition of CD4+ T cell function by the HIV envelope protein, gp120.J Immunol1988https://conductscience.org/library/papers/2846691PubMed
82851650Inhibitory influences of envelope glycoproteins of HIV-1 on normal immune responses.J Acquir Immune Defic Syndr (1988)1988https://conductscience.org/library/papers/2851650PubMed
92540772An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1.AIDS1989https://conductscience.org/library/papers/2540772PubMed
102469721Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes.J Immunol1989https://conductscience.org/library/papers/2469721PubMed
112471813Specificity and function of the individual amino acids of an important determinant of human immunodeficiency virus type 1 that induces neutralizing activity.J Gen Virol1989https://conductscience.org/library/papers/2471813PubMed
122771954Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2771954PubMed
132571187Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation.Science1989https://conductscience.org/library/papers/2571187PubMed
142552068HIV-1 peptides induce a proliferative response in lymphocytes from infected persons.J Acquir Immune Defic Syndr (1988)1989https://conductscience.org/library/papers/2552068PubMed
153014647Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein.Science1986https://conductscience.org/library/papers/3014647PubMed
163014663Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects.Science1986https://conductscience.org/library/papers/3014663PubMed
172431482HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope.Science1986https://conductscience.org/library/papers/2431482PubMed
183466790Induction of anti-HIV neutralizing antibodies by synthetic peptides.EMBO J1986https://conductscience.org/library/papers/3466790PubMed
192438696
Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide.
Proc Natl Acad Sci U S A1987https://conductscience.org/library/papers/2438696PubMed
203037522Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack.Proc Natl Acad Sci U S A1987https://conductscience.org/library/papers/3037522PubMed

See all 42 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.

PMIDTitleJournalYearIn PapersSource
36807845Gene-encoded nanoparticle vaccine platforms for in vivo assembly of multimeric antigen to promote adaptive immunity.Wiley Interdiscip Rev Nanomed Nanobiotechnol2023https://conductscience.org/library/papers/36807845PubMed
16997714Virus-like particles: passport to immune recognition.Methods2006https://conductscience.org/library/papers/16997714PubMed
11725486Virus-like particles as vaccine adjuvants.Mol Biotechnol2001https://conductscience.org/library/papers/11725486PubMed
9420270Human rhinovirus type 14:human immunodeficiency virus type 1 (HIV-1) V3 loop chimeras from a combinatorial library induce potent neutralizing antibody responses against HIV-1.J Virol1998https://conductscience.org/library/papers/9420270PubMed
8698376Induction of single and dual cytotoxic T-lymphocyte responses to viral proteins in mice using recombinant hybrid Ty-virus-like particles.Immunology1996https://conductscience.org/library/papers/8698376PubMed
8497047Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: induction of cytotoxic T-cell and humoral responses by a Gag:V3 fusion.J Virol1993https://conductscience.org/library/papers/8497047PubMed
8464405Pathogenesis of human immunodeficiency virus infection.Microbiol Rev1993https://conductscience.org/library/papers/8464405PubMed
7915974Enhanced activation of human T cell clones specific for virus-like particles expressing the HIV V3 loop in the presence of HIV V3 loop-specific polyclonal antibodies.Clin Exp Immunol1994https://conductscience.org/library/papers/7915974PubMed
7769663Incorporation of pseudorabies virus gD into human immunodeficiency virus type 1 Gag particles produced in baculovirus-infected cells.J Virol1995https://conductscience.org/library/papers/7769663PubMed
2057382New nucleotide sequence data on the EMBL File Server.Nucleic Acids Res1991https://conductscience.org/library/papers/2057382PubMed
1548782Human immunodeficiency virus type 1 major neutralizing determinant exposed on hepatitis B surface antigen particles is highly immunogenic in primates.J Virol1992https://conductscience.org/library/papers/1548782PubMed
1433504Localization of an immunodominant domain on baculovirus-produced parvovirus B19 capsids: correlation to a major surface region on the native virus particle.J Virol1992https://conductscience.org/library/papers/1433504PubMed
1373205Poliovirus chimeras expressing sequences from the principal neutralization domain of human immunodeficiency virus type 1.J Virol1992https://conductscience.org/library/papers/1373205PubMed
1362183Enhanced proliferative cellular responses to HIV-1 V3 peptide and gp120 following immunization with V3:Ty virus-like particles.Immunology1992https://conductscience.org/library/papers/1362183PubMed

Download CSV of cited by

Data10

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccessionSource
GENBANKM62767GENBANK
GENBANKM63040GENBANK
GENBANKM63041GENBANK
GENBANKM63042GENBANK
GENBANKM63043GENBANK
GENBANKM63044GENBANK
GENBANKM63045GENBANK
GENBANKM63046GENBANK
GENBANKM63047GENBANK
GENBANKM63048GENBANK

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1985208

GET https://conductscience.org/api/papers/v1/1985208/references?page=2